BioMedomics™ Sickle SCAN® is a multiplexed, qualitative, point-of-care immunoassay to aid in the rapid diagnosis of sickle cell disorders.
The test is made up of three indicators which detect the presence of hemoglobins A, S, and C, allowing the user to rapidly distinguish between normal, carrier, and sickle cell disease samples.
Sickle SCAN® has both a combined sensitivity and specificity of >99% and provides results in 5 minutes, making it one of the fastest and most accurate tests in the world.
Sickle cell disease (SCD) is an inherited blood disorder which often causes red blood cells (RBCs) to become sickle-shaped through the presence of the abnormal hemoglobin S variant. Highly rigid sickle-shaped blood may have difficulty passing through small blood vessels, blocking the normal blood flow, damaging tissues, and ultimately leading to many of the complications of SCD. Additionally, RBCs containing mostly hemoglobin S live only about 16 days compared to 120 days for normal red blood cells. To initiate life-saving therapies, early diagnosis of SCD is key.
Before Sickle SCAN, SCD diagnosis was only possible using complex lab equipment. In low-resource regions where SCD is responsible for 9% of all under-five infant mortality, infrastructure challenges make central lab testing impractical. Sickle SCAN helps overcome the diagnostic gap. Ideal for providing quick and accurate results at the point-of-care, the test requires no supporting equipment and can also be used preventatively for genetic counseling to reduce the incidence of sickle cell births.
Features & Benefits
The test can be completed in under 5 minutes giving real time results. It uses a small amount of whole blood from a fingerstick, heelstick, or venipuncture.
Compared to traditional central lab testing, Sickle SCAN:
- Eliminates the need to transport samples
- Streamlines the clinical work flow
- Requires no supporting equipment or rigorous training
- Drastically reduces patient waiting time and discomfort
How It Works
1. Collect a 5 µL blood sample.
2. Mix blood with buffer solution
3. Place 5 drops on test strip and wait 5 minutes.
Introducting BioMedomics Sickle SCAN Rapid TestBioMedomics Sickle SCAN is the world’s first rapid, point-of-care test for sickle cell disease and trait. Ideal for providing quick and accurate results for patients and clinical professionals at the point of care, Sickle SCAN is designed to help overcome the existing diagnostic gap in low-resource regions where SCD is responsible for 9% of all under-five infant mortality. The test easily and affordably provides physicians and patients with information vital to making treatment and lifestyle decisions that can reduce the effects and incidence of the disease.